Correction to: Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2167-485X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions ; day:23 ; month:1 ; year:2018 ; pages:1
Current pathobiology reports ; (23.1.2018), 1
- Urheber
-
Mitchell, Ellen L.
- Beteiligte Personen und Organisationen
-
Khan, Zahida
SpringerLink (Online service)
- DOI
-
10.1007/s40139-018-0164-z
- URN
-
urn:nbn:de:1111-2018032111046
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mitchell, Ellen L.
- Khan, Zahida
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alpha-1 antitrypsin deficiency: outstanding questions and future directions
Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease
Liver disease in adults with severe alpha-1-antitrypsin deficiency
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
Alcohol consumption and liver phenotype of individuals with alpha‐1 antitrypsin deficiency
Prolastin, Prolastina, Pulmolast : alpha-1 antitrypsin deficiency
Alpha-1-Antitrypsin [Alpha-Antitrypsin]
The role of mTOR in alpha-1 antitrypsin deficiency related liver disease
Alpha-1 Antitrypsin deficiency : clinical aspects and management
Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
Alpha-1 antitrypsin deficiency: outstanding questions and future directions
Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease
Liver disease in adults with severe alpha-1-antitrypsin deficiency
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
Alcohol consumption and liver phenotype of individuals with alpha‐1 antitrypsin deficiency
Prolastin, Prolastina, Pulmolast : alpha-1 antitrypsin deficiency
Alpha-1-Antitrypsin [Alpha-Antitrypsin]
The role of mTOR in alpha-1 antitrypsin deficiency related liver disease
Alpha-1 Antitrypsin deficiency : clinical aspects and management
Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
Alpha-1 antitrypsin deficiency: outstanding questions and future directions
Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease
Liver disease in adults with severe alpha-1-antitrypsin deficiency
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
Alcohol consumption and liver phenotype of individuals with alpha‐1 antitrypsin deficiency
Prolastin, Prolastina, Pulmolast : alpha-1 antitrypsin deficiency
Alpha-1-Antitrypsin [Alpha-Antitrypsin]
The role of mTOR in alpha-1 antitrypsin deficiency related liver disease
Alpha-1 Antitrypsin deficiency : clinical aspects and management
Survival in severe alpha-1-antitrypsin deficiency (PiZZ)
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences